By using a siRNA against PTPN13 in combination with an inhibitor of IκBα phosphorylation or an IκBα mutant (Y42A), they confirmed that PTPN13 exerts its tumor suppressive effect by dephosphorylating IκBα at Tyr42 [89]. The gene discussed is PTPN13; the disease is neoplasm.